<?xml version="1.0" encoding="UTF-8"?>
<p id="Par54">In this study, we investigated the impact of 
 <italic>UGT1A1*28</italic> and 
 <italic>*6</italic> variants on CR rate after induction chemotherapy, treatment-related mortality (TRM), OS and event-free survival (EFS) in 726 Chinese AML patients treated with Ara-C.
</p>
